Cardiomo Care
Private Company
Funding information not available
Overview
Founded in 2019 and based in San Francisco, Cardiomo Care operates at the intersection of cardiovascular medicine and digital health. The company's core offering is an integrated platform combining proprietary wearable sensors with advanced AI algorithms for remote patient monitoring (RPM). This technology aims to address the growing need for scalable, proactive cardiac care, potentially reducing hospital readmissions and enabling more personalized treatment pathways. As a private, likely pre-revenue or early-revenue stage company, Cardiomo is positioned in a high-growth market driven by an aging population and the expansion of telehealth.
Technology Platform
Integrated platform combining proprietary wearable biosensors for continuous physiological data capture with cloud-based AI/ML analytics for real-time cardiac monitoring and alert generation.
Opportunities
Risk Factors
Competitive Landscape
Cardiomo operates in a crowded and competitive field. Major competitors include established medical device companies like Medtronic (LinQ, SEEQ), Boston Scientific (LUX-Dx), and Philips, as well as a growing number of digital health startups (e.g., iRhythm, AliveCor, Biofourmis). Differentiation hinges on sensor comfort/wearability, algorithm accuracy, clinical validation, and the depth of the software platform's analytics and user experience.